| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |